MohamedAl-IbrahimMD

Senior Investigator, Pharmaron, Clinical Pharmacology Center

Dr. Al-Ibrahim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
827 Linden Ave
Baltimore, MD 21201
Phone+1 410-225-8000

Fax+1 410-706-8963

NYU Grossman School of MedicineFellowship, Infectious Disease, 1973 - 1975
NYU Grossman School of MedicineResidency, Internal Medicine, 1973 - 1974
University of MarylandResidency, Internal Medicine, 1971 - 1972
University of Maryland Medical Center Midtown CampusResidency, Internal Medicine, 1970 - 1971
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1969 - 1970
University of Baghdad College of MedicineClass of 1967

PubMed

286 citations
Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.
Michael S. Simberkoff, Anne Cross, Mohamed S. Al-Ibrahim, A. L. Baltch, P J Geiseler
The New England Journal of Medicine. 1986-11-20
45 citations
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects
Stuart P. Adler, Nicole Lewis, Anthony Conlon, Mark P Christiansen, Mohamed S. Al-Ibrahim
The Journal of Infectious Diseases. 2019-07-02
5 citations
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Jesse Nussbaum, Xin Cao, Radha A Railkar, Jeffrey R Sachs, Daniel S Spellman
Vaccine. 2023-10-20

Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort FreeJune 7th, 2005
Immuron Announces First Patients Enrolled in Travelan® Clinical StudyJuly 26th, 2023